These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10937286)

  • 41. Charged liposomes as carriers to enhance the permeation through the skin.
    González-Rodríguez ML; Rabasco AM
    Expert Opin Drug Deliv; 2011 Jul; 8(7):857-71. PubMed ID: 21557706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Control of in vitro cytotoxicity of positively charged liposomes.
    Panzner EA; Jansons VK
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):29-37. PubMed ID: 500767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.
    Hathout RM; Mansour S; Mortada ND; Guinedi AS
    AAPS PharmSciTech; 2007 Jan; 8(1):1. PubMed ID: 17408209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical delivery of different acyclovir palmitate liposome formulations through rat skin in vitro.
    Liu H; Pan WS; Tang R; Luo SD
    Pharmazie; 2004 Mar; 59(3):203-6. PubMed ID: 15074594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin penetration and retention of L-ascorbic acid 2-phosphate using multilamellar vesicles.
    Yoo J; Shanmugam S; Song CK; Kim DD; Choi HG; Yong CS; Woo JS; Yoo BK
    Arch Pharm Res; 2008 Dec; 31(12):1652-8. PubMed ID: 19099237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving Topical Skin Delivery of Monocrotaline Via Liposome Gel-based Nanosystems.
    Yu J; Chen Z; Yin YZ; Tang C; Hu E; Zheng S; Liu Q; Xiong Y
    Curr Drug Deliv; 2019; 16(10):940-950. PubMed ID: 31660816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deformable liposomes by reverse-phase evaporation method for an enhanced skin delivery of (+)-catechin.
    Chen G; Li D; Jin Y; Zhang W; Teng L; Bunt C; Wen J
    Drug Dev Ind Pharm; 2014 Feb; 40(2):260-5. PubMed ID: 23356860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of liposomes on tryptic digestion of insulin. II.
    Kato Y; Hosokawa T; Hayakawa E; Ito K
    Biol Pharm Bull; 1993 Aug; 16(8):740-4. PubMed ID: 8220318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of dextrans on improving lymphatic drainage for liposomal drug delivery system.
    Feng L; Zhang L; Liu M; Yan Z; Wang C; Gu B; Liu Y; Wei G; Zhong G; Lu W
    J Drug Target; 2010 Apr; 18(3):168-78. PubMed ID: 20136463
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of liposomes on permeability of various compounds through rabbit corneas.
    Morimoto K; Nakamura T; Nakai T; Morisaka K
    Arch Int Pharmacodyn Ther; 1988; 293():7-13. PubMed ID: 3138953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge and drug association.
    Lawrence SM; Alpar HO; McAllister SM; Brown MR
    J Drug Target; 1993; 1(4):303-10. PubMed ID: 8069572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasis.
    Ferreira LS; Ramaldes GA; Nunan EA; Ferreira LA
    Drug Dev Ind Pharm; 2004 Mar; 30(3):289-96. PubMed ID: 15109028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of novel topical tranexamic acid liposome formulations.
    Manosroi A; Podjanasoonthon K; Manosroi J
    Int J Pharm; 2002 Mar; 235(1-2):61-70. PubMed ID: 11879740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin.
    Raza K; Singh B; Mahajan A; Negi P; Bhatia A; Katare OP
    J Drug Target; 2011 May; 19(4):293-302. PubMed ID: 20615093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphatic targeting of zidovudine using surface-engineered liposomes.
    Kaur CD; Nahar M; Jain NK
    J Drug Target; 2008 Dec; 16(10):798-805. PubMed ID: 19005941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impregnation of collagen corneal shields with liposomes: uptake and release of hydrophilic and lipophilic marker substances.
    Grammer JB; Kortüm FA; Wolburg H; Lüdtke R; Schmidt KH; Thiel HJ; Pleyer U
    Curr Eye Res; 1996 Aug; 15(8):815-23. PubMed ID: 8921224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality by Design-Driven Zeta Potential Optimisation Study of Liposomes with Charge Imparting Membrane Additives.
    Németh Z; Csóka I; Semnani Jazani R; Sipos B; Haspel H; Kozma G; Kónya Z; Dobó DG
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Besifloxacin liposomes with positively charged additives for an improved topical ocular delivery.
    Dos Santos GA; Ferreira-Nunes R; Dalmolin LF; Dos Santos Ré AC; Anjos JLV; Mendanha SA; Aires CP; Lopez RFV; Cunha-Filho M; Gelfuso GM; Gratieri T
    Sci Rep; 2020 Nov; 10(1):19285. PubMed ID: 33159142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liposomes as carriers for topical and transdermal delivery.
    Touitou E; Junginger HE; Weiner ND; Nagai T; Mezei M
    J Pharm Sci; 1994 Sep; 83(9):1189-203. PubMed ID: 7830230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dextran sulfate-dependent fusion of liposomes containing cationic stearylamine.
    Zschörnig O; Arnold K; Richter W; Ohki S
    Chem Phys Lipids; 1992 Nov; 63(1-2):15-22. PubMed ID: 1486657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.